000			01959 a2200565 4500
005			20250517093051.0
264		0	_c20180122
008			201801s 0 0 eng d
022			_a2160-7648
024	7		_a10.1002/cpdd.129 _2doi
040			_aNLM _beng _cNLM
100	1		_aMoffett, Brady S
245	0	0	_aBioequivalence of enalapril oral solution for treatment of pediatric hypertension and enalapril tablets. _h[electronic resource]
260			_bClinical pharmacology in drug development _c11 2014
300			_a493-8 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAge of Onset
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xadministration & dosage
650	0	4	_aAntihypertensive Agents _xadministration & dosage
650	0	4	_aArea Under Curve
650	0	4	_aBiological Availability
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aChromatography, Liquid
650	0	4	_aCross-Over Studies
650	0	4	_aDrug Compounding
650	0	4	_aDrug Monitoring _xmethods
650	0	4	_aEnalapril _xadministration & dosage
650	0	4	_aFasting _xblood
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHypertension _xdiagnosis
650	0	4	_aMale
650	0	4	_aMetabolic Clearance Rate
650	0	4	_aMiddle Aged
650	0	4	_aPharmaceutical Solutions
650	0	4	_aTablets
650	0	4	_aTandem Mass Spectrometry
650	0	4	_aTherapeutic Equivalency
650	0	4	_aYoung Adult
700	1		_aDiSanto, Anthony R
700	1		_aEspinosa, Orlando
700	1		_aHou, Jingguo
700	1		_aColabuono, Peter
773	0		_tClinical pharmacology in drug development _gvol. 3 _gno. 6 _gp. 493-8
856	4	0	_uhttps://doi.org/10.1002/cpdd.129 _zAvailable from publisher's website
999			_c25972499 _d25972499